Skip to content

Corvus Pharmaceuticals, Inc.

CRVS Nasdaq SEC CIK 1626971

Follow Corvus Pharmaceuticals Weekly email: filings, results, news

News

3 stories filed under Corvus Pharmaceuticals

Markets

Thread · 2 stories

Corvus Pharmaceuticals: Steady As She Goes With Strong Footing In Atopic Dermatitis Treatment

Markets 28 d ago

Corvus Pharmaceuticals (CRVS): This Clinical-Stage Drugmaker Just Got A Lot More Interesting

Markets 38 d ago

More coverage

Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript

Earnings 48 d ago

Next results

NOV5

Q1 2026 results

Thursday · estimated from the filing cadence

Profile

Headquarters: SOUTH SAN FRANCISCO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 3 stories clustered from the RSS aggregator